Authors:
Tominaga, T
Koyama, H
Nomura, Y
Miura, S
Morimoto, T
Citation: T. Tominaga et al., Primary breast cancer patients treated with breast-conserving therapy and tamoxifen - Do they always require radiotherapy?, CLIN DRUG I, 21(11), 2001, pp. 775-782
Authors:
Tominaga, T
Sano, M
Nishi, T
Sasaki, M
Yoshida, K
Kimura, M
Takashima, S
Asano, T
Yoshida, M
Fujiwara, J
Danno, M
Citation: T. Tominaga et al., Postoperative chemoendocrine therapy for women with node-positive stage IIbreast cancer with combined cyclophosphamide, tamoxifen, and 1-hexylcarbamoyl-5-fluorouracil, EURO J SURG, 167(8), 2001, pp. 598-604
Authors:
Okamoto, K
Hirota, N
Tominaga, T
Terazima, M
Citation: K. Okamoto et al., Translational diffusion of ion radicals created by electron transfer in charged micellar solutions probed by the transient grating method and the Taylor dispersion method, J PHYS CH A, 105(27), 2001, pp. 6586-6593
Citation: K. Fujimoto-ouchi et al., Schedule dependency of antitumor activity in combination therapy with capecitabine/5 '-deoxy-5-fluorouridine and docetaxel in breast cancer models, CLIN CANC R, 7(4), 2001, pp. 1079-1086
Authors:
Ide, A
Ashizawa, K
Ishikawa, N
Ishii, R
Ando, T
Abe, Y
Sera, N
Usa, T
Tominaga, T
Ejima, E
Nakashima, M
Ito, K
Ito, K
Eguchi, K
Citation: A. Ide et al., Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma, THYROID, 11(11), 2001, pp. 1055-1061
Authors:
Yajima, A
Ogawa, Y
Ikehara, A
Tominaga, T
Inou, T
Otsubo, O
Citation: A. Yajima et al., Development of low-turnover bone diseases after parathyroidectomy and autotransplantation, INT J UROL, 8(8), 2001, pp. S76-S79
Authors:
Akahoshi, M
Amasaki, Y
Soda, M
Tominaga, T
Ichimaru, S
Nakashima, E
Seto, S
Yano, K
Citation: M. Akahoshi et al., Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan, HYPERTENS R, 24(4), 2001, pp. 337-343
Authors:
Klijn, JGM
Blamey, RW
Boccardo, F
Tominaga, T
Duchateau, L
Sylvester, R
Citation: Jgm. Klijn et al., Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials, J CL ONCOL, 19(2), 2001, pp. 343-353
Authors:
Toshima, N
Shiraishi, Y
Teranishi, T
Miyake, M
Tominaga, T
Watanabe, H
Brijoux, W
Bonnemann, H
Schmid, G
Citation: N. Toshima et al., Various ligand-stabilized metal nanoclusters as homogeneous and heterogeneous catalysts in the liquid phase, APPL ORGAN, 15(3), 2001, pp. 178-196
Authors:
Matsumoto, K
Kizaki, Y
Fukae, S
Tomihira, M
Sera, Y
Ueki, Y
Tominaga, T
Miyake, S
Citation: K. Matsumoto et al., Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease, DIABET RE C, 51(3), 2001, pp. 181-186
Authors:
Pant, S
Ohtaka-Saiki, H
Takezaki, M
Tominaga, T
Citation: S. Pant et al., Interactions between a tetraanionic porphyrin and the methylviologen dication in methanol studied by fluorescence quenching reaction, J MOL LIQ, 90(1-3), 2001, pp. 121-130
Authors:
Yamashita, Y
Kumabe, T
Jokura, H
Tominaga, T
Yoshimoto, T
Citation: Y. Yamashita et al., Intracranial dissemination from thoracic spinal cord anaplastic astrocytoma in a patient with idiopathic CD4-positive T lymphocytopenia - A case report, SURG NEUROL, 56(1), 2001, pp. 39-41
Citation: T. Tominaga et al., Simultaneous multi-site recordings of neural activity with an inline multi-electrode array and optical measurement in rat hippocampal slices, PFLUG ARCH, 443(2), 2001, pp. 317-322
Authors:
Abe, Y
Kawakami, A
Nakashima, T
Ejima, E
Fujiyama, K
Kiriyama, T
Ide, A
Sera, N
Usa, T
Tominaga, T
Ashizawa, K
Yokoyama, N
Eguchi, K
Citation: Y. Abe et al., Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells (vol 136, pg 344, 2000), J LA CL MED, 137(2), 2001, pp. 141-141
Citation: S. Satoh et T. Tominaga, mDia-interacting protein acts downstream of Rho-mDia and modifies Src activation and stress fiber formation, J BIOL CHEM, 276(42), 2001, pp. 39290-39294
Citation: Ml. Murat et al., Assessing the aromatic potential of Cabernet Sauvignon and Merlot musts used to produce rose wine by assaying the cysteinylated precursor of 3-mercaptohexan-1-ol, J AGR FOOD, 49(11), 2001, pp. 5412-5417
Citation: L. Blanchard et al., Formation of furfurylthiol exhibiting a strong coffee aroma during oak barrel fermentation from furfural released by toasted staves, J AGR FOOD, 49(10), 2001, pp. 4833-4835
Authors:
Sera, N
Kawakami, A
Nakashima, T
Nakamura, H
Imaizumi, M
Koji, T
Abe, Y
Usa, T
Tominaga, T
Ejima, E
Ashizawa, K
Yokoyama, N
Ishikawa, N
Ito, K
Eguchi, K
Citation: N. Sera et al., Fas/FasL mediated apoptosis of thyrocytes in Graves' disease, CLIN EXP IM, 124(2), 2001, pp. 197-207
Authors:
Murat, ML
Masneuf, I
Darriet, P
Lavigne, V
Tominaga, T
Dubourdieu, D
Citation: Ml. Murat et al., Effect of Saccharomyces cerevisiae yeast strains on the liberation of volatile thiols in Sauvignon blanc wine, AM J ENOL V, 52(2), 2001, pp. 136-139
Authors:
Karibe, H
Tominaga, T
Sato, K
Yoshimoto, T
Citation: H. Karibe et al., Decrease in intraoperative brain surface temperature in patients with subarachnoid haemorrhage, ACT NEUROCH, 143(1), 2001, pp. 9-15
Authors:
Sera, N
Yokoyama, N
Abe, Y
Ide, A
Imaizumi, M
Usa, T
Tominaga, T
Ejima, E
Ashizawa, K
Ohmoto, Y
Eguchi, K
Citation: N. Sera et al., Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors, THYROID, 10(8), 2000, pp. 641-646
Authors:
Sera, N
Ashizawa, K
Ando, T
Abe, Y
Ide, A
Usa, T
Tominaga, T
Ejima, E
Yokoyama, N
Eguchi, K
Citation: N. Sera et al., Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease, THYROID, 10(7), 2000, pp. 595-599